NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
UMIN ID: UMIN000015978

Registered date:17/12/2014

Establishment of assay system for zinc in whole blood

Basic Information

Recruitment status Complete: follow-up complete
Health condition(s) or Problem(s) studiedZinc deficiency
Date of first enrollment2014/12/17
Target sample size20
Countries of recruitmentJapan
Study typeInterventional
Intervention(s)To intake zinc-containing supplement.Seven days, at the regular supplement doses. To draw peripheral blood before and after the inake of zinc supplement. About 15 ml for blood cell count,chemistry and zinc level measurement.

Outcome(s)

Primary OutcomeZinc content in red blood cells can be measured using the assay system for plasama zinc.
Secondary OutcomeAfter uptake of zinc supplement, zinc contents in both plasma and red cells demonstrate increment.

Key inclusion & exclusion criteria

Age minimum20years-old
Age maximum65years-old
GenderMale and Female
Include criteria
Exclude criteriaNothing

Related Information

Contact

public contact
Name Kenji Ikebuchi
Address 1397-1,Yamane, Hidaka City, Saitama Japan
Telephone 042-984-4383
E-mail ikebuchi@saitama-med.ac.jp
Affiliation Saitama Medical University International Medical Center Laboratory Medicine Department
scientific contact
Name Kenji Ikebuchi
Address 1397-1, Yamane, Hidaka City, Saitama, Japan Japan
Telephone 042-984-4383
E-mail ikebuchi@saitama-med.ac.jp
Affiliation Saitama Medical University International Medical Center Laboratory Department